Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Novo ends all cell therapy R&D, lets go of staff
Novo is looking for partners to further develop its cell therapy programs, a spokesperson told Fierce Biotech.
Gabrielle Masson
Oct 10, 2025 3:30pm
MIT rejects Trump deal tying research money to certain demands
Oct 10, 2025 1:12pm
AstraZeneca: Building a transparent pipeline from the ground up
Oct 10, 2025 9:52am
ARPA-H goes all in on in vivo cell therapy
Oct 8, 2025 4:04pm
Sanofi inks pact with Canadian tech company to bring AI to R&D
Oct 8, 2025 12:13pm
GLD flexes muscle-wasting ambitions, launching Altagenics
Oct 7, 2025 10:01am
